000 01315 a2200385 4500
005 20250516140435.0
264 0 _c20140506
008 201405s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/1381612811319350003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoribe, Kunikazu
245 0 0 _aNano-sized crystalline drug production by milling technology.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2013
300 _a6246-58 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCrystallization
650 0 4 _aDrug Compounding
_xmethods
650 0 4 _aDrug Design
650 0 4 _aExcipients
_xchemistry
650 0 4 _aHumans
650 0 4 _aNanoparticles
650 0 4 _aParticle Size
650 0 4 _aPharmaceutical Preparations
_xadministration & dosage
650 0 4 _aQuality Control
650 0 4 _aSolubility
650 0 4 _aTechnology, Pharmaceutical
_xmethods
700 1 _aUeda, Keisuke
700 1 _aLimwikrant, Waree
700 1 _aHigashi, Kenjirou
700 1 _aYamamoto, Keiji
773 0 _tCurrent pharmaceutical design
_gvol. 19
_gno. 35
_gp. 6246-58
856 4 0 _uhttps://doi.org/10.2174/1381612811319350003
_zAvailable from publisher's website
999 _c22562219
_d22562219